Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 28 | 2025 | 682 | 5.450 |
Why?
|
| Registries | 19 | 2025 | 1634 | 1.610 |
Why?
|
| Cardiopulmonary Resuscitation | 4 | 2025 | 229 | 1.250 |
Why?
|
| Delphi Technique | 2 | 2024 | 283 | 0.950 |
Why?
|
| Peripartum Period | 3 | 2025 | 29 | 0.920 |
Why?
|
| Norwood Procedures | 1 | 2024 | 96 | 0.780 |
Why?
|
| Hospital Mortality | 5 | 2024 | 1064 | 0.780 |
Why?
|
| Respiratory Insufficiency | 3 | 2021 | 247 | 0.780 |
Why?
|
| Heart Defects, Congenital | 4 | 2023 | 1889 | 0.720 |
Why?
|
| Hypertension, Pulmonary | 2 | 2025 | 457 | 0.720 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2024 | 325 | 0.710 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2024 | 261 | 0.680 |
Why?
|
| Blalock-Taussig Procedure | 1 | 2021 | 46 | 0.670 |
Why?
|
| Heart Arrest | 1 | 2025 | 356 | 0.670 |
Why?
|
| Critical Illness | 2 | 2024 | 630 | 0.640 |
Why?
|
| Palliative Care | 1 | 2024 | 443 | 0.630 |
Why?
|
| Survival Analysis | 1 | 2022 | 1483 | 0.550 |
Why?
|
| Retrospective Studies | 24 | 2025 | 17753 | 0.540 |
Why?
|
| Catheterization, Central Venous | 1 | 2019 | 143 | 0.520 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 164 | 0.520 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 270 | 0.460 |
Why?
|
| Shock, Cardiogenic | 5 | 2024 | 176 | 0.450 |
Why?
|
| Heart-Assist Devices | 5 | 2022 | 1020 | 0.450 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2019 | 500 | 0.440 |
Why?
|
| Heart Transplantation | 5 | 2026 | 800 | 0.440 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 514 | 0.430 |
Why?
|
| Child Abuse | 1 | 2017 | 228 | 0.400 |
Why?
|
| Survival Rate | 4 | 2024 | 2114 | 0.370 |
Why?
|
| Humans | 48 | 2026 | 131163 | 0.370 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2021 | 1280 | 0.360 |
Why?
|
| Child | 20 | 2026 | 26341 | 0.350 |
Why?
|
| Length of Stay | 3 | 2024 | 1421 | 0.330 |
Why?
|
| Heart Failure | 5 | 2022 | 2332 | 0.330 |
Why?
|
| Female | 27 | 2026 | 70963 | 0.320 |
Why?
|
| Anticoagulants | 2 | 2024 | 605 | 0.300 |
Why?
|
| Adult | 20 | 2025 | 31282 | 0.300 |
Why?
|
| Hypoxia | 2 | 2024 | 247 | 0.280 |
Why?
|
| Treatment Outcome | 8 | 2025 | 12936 | 0.260 |
Why?
|
| Infant | 9 | 2025 | 13352 | 0.260 |
Why?
|
| Male | 22 | 2026 | 64957 | 0.260 |
Why?
|
| Hemodynamic Monitoring | 1 | 2026 | 17 | 0.240 |
Why?
|
| Child, Preschool | 7 | 2025 | 15110 | 0.230 |
Why?
|
| Cardiac Output | 1 | 2026 | 153 | 0.230 |
Why?
|
| Hydrogen | 1 | 2025 | 37 | 0.220 |
Why?
|
| Meningioma | 5 | 1998 | 151 | 0.210 |
Why?
|
| Ventilators, Mechanical | 1 | 2025 | 44 | 0.210 |
Why?
|
| Meningeal Neoplasms | 5 | 1998 | 220 | 0.210 |
Why?
|
| Respiration, Artificial | 2 | 2025 | 501 | 0.200 |
Why?
|
| Cardiac Tamponade | 1 | 2023 | 35 | 0.200 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2024 | 58 | 0.200 |
Why?
|
| Adolescent | 9 | 2026 | 20987 | 0.200 |
Why?
|
| Postoperative Period | 1 | 2024 | 331 | 0.200 |
Why?
|
| Compartment Syndromes | 1 | 2023 | 35 | 0.190 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2025 | 229 | 0.180 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2022 | 20 | 0.180 |
Why?
|
| Pregnancy | 4 | 2025 | 7512 | 0.180 |
Why?
|
| Consensus | 1 | 2024 | 512 | 0.180 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2022 | 27 | 0.180 |
Why?
|
| Granulomatosis with Polyangiitis | 1 | 2022 | 39 | 0.180 |
Why?
|
| Hydroxyurea | 3 | 1997 | 89 | 0.180 |
Why?
|
| Myositis | 1 | 2022 | 84 | 0.170 |
Why?
|
| Blood Pressure | 2 | 2024 | 1345 | 0.170 |
Why?
|
| Pulmonary Circulation | 1 | 2021 | 113 | 0.170 |
Why?
|
| Morbidity | 1 | 2021 | 256 | 0.160 |
Why?
|
| Shock | 1 | 2022 | 100 | 0.160 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 167 | 0.160 |
Why?
|
| Infant, Newborn | 5 | 2024 | 8635 | 0.160 |
Why?
|
| Prospective Studies | 3 | 2026 | 6459 | 0.150 |
Why?
|
| Antithrombins | 1 | 2019 | 49 | 0.150 |
Why?
|
| Brain Injuries | 1 | 2024 | 710 | 0.150 |
Why?
|
| Risk Factors | 4 | 2023 | 11074 | 0.150 |
Why?
|
| Postpartum Period | 1 | 2021 | 245 | 0.140 |
Why?
|
| Thrombosis | 2 | 2024 | 499 | 0.140 |
Why?
|
| Hospitals | 1 | 2021 | 435 | 0.140 |
Why?
|
| Central Venous Catheters | 1 | 2019 | 50 | 0.140 |
Why?
|
| Middle Aged | 11 | 2025 | 28601 | 0.140 |
Why?
|
| Vancomycin | 1 | 2020 | 226 | 0.140 |
Why?
|
| Critical Care | 2 | 2021 | 686 | 0.140 |
Why?
|
| Heparin | 1 | 2019 | 208 | 0.140 |
Why?
|
| Pulmonary Artery | 1 | 2021 | 434 | 0.140 |
Why?
|
| Cohort Studies | 3 | 2022 | 5063 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 275 | 0.130 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 182 | 0.130 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2019 | 361 | 0.120 |
Why?
|
| Veins | 1 | 2017 | 95 | 0.120 |
Why?
|
| Osteosarcoma | 1 | 2019 | 276 | 0.120 |
Why?
|
| Arteries | 1 | 2017 | 208 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 339 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 351 | 0.110 |
Why?
|
| Young Adult | 4 | 2025 | 10103 | 0.110 |
Why?
|
| Biomarkers | 1 | 2024 | 3385 | 0.110 |
Why?
|
| Status Asthmaticus | 1 | 2014 | 23 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 475 | 0.100 |
Why?
|
| Aged | 5 | 2025 | 21025 | 0.100 |
Why?
|
| Antineoplastic Agents | 4 | 1998 | 1826 | 0.100 |
Why?
|
| Anaphylaxis | 1 | 2014 | 94 | 0.100 |
Why?
|
| Haemophilus Infections | 1 | 2012 | 97 | 0.090 |
Why?
|
| Haemophilus influenzae | 1 | 2012 | 134 | 0.090 |
Why?
|
| United States | 3 | 2024 | 12072 | 0.090 |
Why?
|
| Incidence | 1 | 2019 | 3360 | 0.080 |
Why?
|
| Equipment Design | 2 | 2025 | 512 | 0.080 |
Why?
|
| Time Factors | 1 | 2019 | 6196 | 0.070 |
Why?
|
| Sepsis | 1 | 2012 | 493 | 0.070 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2017 | 1168 | 0.070 |
Why?
|
| Hemodynamics | 2 | 2022 | 810 | 0.060 |
Why?
|
| Photoplethysmography | 1 | 2026 | 11 | 0.060 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2026 | 18 | 0.060 |
Why?
|
| Thermodilution | 1 | 2026 | 15 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2015 | 1147 | 0.060 |
Why?
|
| Tidal Volume | 1 | 2025 | 42 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 109 | 0.050 |
Why?
|
| Perioperative Period | 1 | 2024 | 48 | 0.050 |
Why?
|
| Monitoring, Physiologic | 1 | 2026 | 376 | 0.050 |
Why?
|
| Hemolysis | 1 | 2024 | 86 | 0.050 |
Why?
|
| Fasciotomy | 1 | 2023 | 26 | 0.050 |
Why?
|
| Fatal Outcome | 2 | 2015 | 352 | 0.050 |
Why?
|
| Benchmarking | 1 | 2023 | 137 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 78 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2004 | 190 | 0.050 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2022 | 40 | 0.040 |
Why?
|
| Cardiac Catheterization | 1 | 2026 | 630 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2024 | 217 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2022 | 294 | 0.040 |
Why?
|
| Oxygen | 1 | 2025 | 548 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2004 | 515 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2024 | 487 | 0.040 |
Why?
|
| Ireland | 1 | 2020 | 33 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2022 | 208 | 0.040 |
Why?
|
| Germany | 1 | 2020 | 61 | 0.040 |
Why?
|
| Cognition Disorders | 1 | 2004 | 556 | 0.040 |
Why?
|
| Body Weights and Measures | 1 | 2019 | 33 | 0.040 |
Why?
|
| Half-Life | 1 | 2019 | 149 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2024 | 514 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2026 | 2904 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2019 | 1618 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 523 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 263 | 0.040 |
Why?
|
| Growth Inhibitors | 1 | 1998 | 35 | 0.030 |
Why?
|
| Autocrine Communication | 1 | 1998 | 30 | 0.030 |
Why?
|
| Heart Neoplasms | 1 | 2019 | 106 | 0.030 |
Why?
|
| Lymphokines | 1 | 1998 | 62 | 0.030 |
Why?
|
| Hospital Costs | 1 | 2019 | 188 | 0.030 |
Why?
|
| Milk Proteins | 1 | 1998 | 95 | 0.030 |
Why?
|
| Body Composition | 1 | 2019 | 545 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 915 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 674 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 713 | 0.030 |
Why?
|
| Heart Atria | 1 | 2019 | 343 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 1998 | 412 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 1996 | 87 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 808 | 0.030 |
Why?
|
| Peptides | 1 | 1998 | 708 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1240 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 1118 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2004 | 3147 | 0.020 |
Why?
|
| Cytokines | 1 | 1998 | 1339 | 0.020 |
Why?
|
| Hospitalization | 1 | 2020 | 1950 | 0.020 |
Why?
|
| Cell Division | 3 | 1998 | 718 | 0.020 |
Why?
|
| Apoptosis | 1 | 1997 | 1827 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2596 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1997 | 3763 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2012 | 1882 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 2 | 1998 | 975 | 0.010 |
Why?
|
| Constriction | 1 | 2004 | 46 | 0.010 |
Why?
|
| Intracranial Embolism | 1 | 2004 | 26 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 238 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2004 | 127 | 0.010 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2004 | 246 | 0.010 |
Why?
|
| Aorta | 1 | 2004 | 521 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2004 | 960 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 1997 | 1272 | 0.010 |
Why?
|
| Aorta, Thoracic | 1 | 2004 | 530 | 0.010 |
Why?
|
| Comorbidity | 1 | 2004 | 1595 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 1998 | 3 | 0.010 |
Why?
|
| Oncostatin M | 1 | 1998 | 4 | 0.010 |
Why?
|
| Receptors, OSM-LIF | 1 | 1998 | 6 | 0.010 |
Why?
|
| Cytokine Receptor gp130 | 1 | 1998 | 12 | 0.010 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1998 | 27 | 0.010 |
Why?
|
| Acute-Phase Proteins | 1 | 1998 | 44 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 1998 | 65 | 0.010 |
Why?
|
| Receptors, Interleukin-6 | 1 | 1998 | 40 | 0.010 |
Why?
|
| Growth Substances | 1 | 1998 | 99 | 0.010 |
Why?
|
| Cell Count | 1 | 1998 | 212 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 1998 | 81 | 0.010 |
Why?
|
| STAT5 Transcription Factor | 1 | 1998 | 93 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1997 | 39 | 0.010 |
Why?
|
| Neuropeptides | 1 | 1998 | 106 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1997 | 53 | 0.010 |
Why?
|
| Steroids | 1 | 1998 | 170 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1997 | 358 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 1998 | 229 | 0.010 |
Why?
|
| Antigens, CD | 1 | 1998 | 410 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 1998 | 405 | 0.010 |
Why?
|
| Mice, Nude | 1 | 1997 | 700 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1997 | 594 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 1319 | 0.010 |
Why?
|
| Trans-Activators | 1 | 1998 | 697 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 1363 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 1216 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 1998 | 1939 | 0.000 |
Why?
|
| Prognosis | 1 | 1996 | 4886 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1998 | 4686 | 0.000 |
Why?
|
| Brain | 1 | 1996 | 3175 | 0.000 |
Why?
|
| Mice | 1 | 1997 | 18301 | 0.000 |
Why?
|
| Animals | 1 | 1997 | 33912 | 0.000 |
Why?
|